Side-by-side financials for BDTX and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BDTX | BNTX |
|---|---|---|
| Market cap | - | $22.90 B |
| US-listed rank | - | #572 |
| Revenue (latest FY) | $70.00M | - |
| Net income (latest FY) | $22.37B | - |
| Net margin | 31952.9% | - |
| SEC filings | 470 | 548 |
Full pages: Black Diamond Therapeutics, Inc. and BioNTech SE, or browse the full rankings.